Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexmedetomidine for prevention of acute kidney injury after Whipple surgery
PACTR202408886014501Phase 4Recruiting
- Sponsor
- National Liver Institute
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in acute kidney failure (AKF) (2 arms), sponsored by National Liver Institute. Primary endpoint: Renal function tests: urea and creatinine. Started Apr 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on PACTR202408886014501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408886014501.